Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities

@inproceedings{Hu2019CancerIB,
  title={Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities},
  author={Weilei Hu and Guosheng Wang and Dongsheng Huang and Meihua Sui and Yibing Xu},
  booktitle={Front. Immunol.},
  year={2019}
}
Cancer immunotherapy has been firmly established as a new milestone for cancer therapy, with the development of multiple immune cells as therapeutic tools. Natural killer (NK) cells are innate immune cells endowed with potent cytolytic activity against tumors, and meanwhile act as regulatory cells for the immune system. The efficacy of NK cell-mediated immunotherapy can be enhanced by immune stimulants such as cytokines and antibodies, and adoptive transfer of activated NK cells expanded ex… CONTINUE READING

Similar Papers

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 175 REFERENCES

Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2016
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

NK cell-based immunotherapy for cancer.

  • Seminars in immunology
  • 2017
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Immune surveillance properties of human NK cell-derived exosomes.

  • Journal of immunology
  • 2012
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL